Who We Are
Biologics by McKesson specialty pharmacy is a leader in creating truly exceptional patient experiences by simplifying connections for providers and delivering personalized care for every patient who we have the honor of serving.
We Focus on Our Patients
At Biologics specialty pharmacy, we focus on why we do what we do: our patients and the partners we work with. We specialize in cancer and rare disease areas. Our goals are to simplify access to therapies and deliver personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes. We also provide benefits investigation, assist with prior authorizations and help patients find financial aid so they can afford their treatment.
Setting the Standard
With over 25 years’ experience caring for patients with cancer and other complex and rare diseases, Biologics has a strong foundation of clinical care with our multidisciplinary care team, and we’ve built on that approach by layering in partnerships, programs and technology that allow us to further elevate the way we care for our patients and the access we can provide them.
What can we help you with today?
Biologics by McKesson News
AYVAKIT™ (avapritinib), FDA Approved for Treatment of PDGFRA Exon 18 Mutant GIST, Available at Biologics by McKesson
CARY, N.C., Jan. 17, 2020—Biologics by McKesson, an independent specialty pharmacy for oncology and other rare and complex therapeutic areas, has been selected by Blueprint Medicines...
Exclusive distribution agreement with Daiichi Sankyo, Inc. expands rare disease and complex therapeutic specialty pharmacy needs CARY, N.C. (August 7, 2019) — Biologics by McKesson, an...
NUBEQA® (darolutamide), FDA Approved for Treatment of High-Risk Non-Metastatic Prostate Cancer, Available at Biologics by McKesson
CARY, N.C., August 1, 2019—Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, was selected by Bayer HealthCare as a specialty...